Sort
64,565 grants matching “drug discovery”
Viral RNA Modifying Enzymes
$483,890Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2007 · GM
Metagenomic detection of emerging viruses in the blood supply
$483,882Eric L. Delwart · Vitalant · R01 · FY2015 · HL
Modeling human phosphorylation networks through kinome-wide profiling
$483,863Benjamin E Turk · Yale University · R01 · FY2014 · GM
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief
$483,858Vsevolod Katritch · University Of Southern California · UG3 · FY2020 · NS
Development of platform technology to measure kinetics and equilibrium concentration of sickle hemoglobin polymerization in single RBCs for drug potency assessment and patient risk stratification
$483,852John Matthew Higgins · Massachusetts General Hospital · R33 · FY2025 · HL
2/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes
$483,807Mark J Daly · Broad Institute, Inc. · U01 · FY2013 · MH
High volume screening for P450 induction
$483,803Puracyp, Inc. · R44 · FY2002 · GM
Biacore 4000 High Throughput System
$483,772Aykut Uren · Georgetown University · S10 · FY2015 · OD
Combinatorial, Catalytic Functionalization of Alkenes and Alkynes
$483,750Keary Mark Engle · Scripps Research Institute, The · R35 · FY2017 · GM
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2018 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2021 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2019 · OD
Combinatorial, Catalytic Functionalization of Alkenes and Alkynes
$483,750Keary Mark Engle · Scripps Research Institute, The · R35 · FY2019 · GM
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2022 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2020 · OD
Combinatorial, Catalytic Functionalization of Alkenes and Alkynes
$483,750Keary Mark Engle · Scripps Research Institute, The · R35 · FY2018 · GM
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity
$483,735James P Luyendyk · Michigan State University · R01 · FY2024 · DK
Mechanism of Action
$483,712David R Andes · University Of Wisconsin-Madison · U19 · FY2014 · AI
REPEAT-CONTAINING RNA BINDING PROTEINS OF TRYPANOSOMES
$483,685Inna Afasizheva · Boston University Medical Campus · R01 · FY2024 · AI
Molecular Basis of Cannabinoid Activity
$483,666Alexandros Makriyannis · Northeastern University · R01 · FY2013 · DA
Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs
$483,655Sendurai Ayyavoo Mani · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Synthetic cathinones: a new class of illicit drugs affecting DAT & SERT
$483,644Louis J De Felice · Virginia Commonwealth University · R01 · FY2013 · DA
Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer
$483,637Ashley M Stokes · St. Joseph'S Hospital And Medical Center · UH3 · FY2024 · CA
Mechanisms of Biosynthetic Formation of Deoxy Sugars
$483,567Hung-Wen Liu · University Of Texas At Austin · R01 · FY2010 · GM
Molecular Basis of Cannabinoid Activity
$483,515Alexandros Makriyannis · Northeastern University · R01 · FY2014 · DA